SummitTX Capital’s Oscar Health OSCR Stock Holding History

SummitTX Capital’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,373	Closed	-$348K	–	901
2025 Q3	$348K	Buy	+18,373	New	+$303K	0.01%	599

Other funds holding OSCR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SummitTX Capital's OSCR Position: Q4 2025 in Review

SummitTX Capital sold out of Oscar Health (OSCR) in Q4 2025, closing a stake of 18,373 shares — an estimated $348K sold.

SummitTX Capital first reported a position in OSCR in Q3 2025 and held it in 1 quarter. The position peaked at $348K in Q3 2025. 341 funds tracked by Wall St. Rank hold OSCR as of Q4 2025.

SummitTX Capital reported no remaining Oscar Health position as of Q4 2025 after selling out during the quarter.
SummitTX Capital sold 18,373 Oscar Health shares in Q4 2025, an estimated $348K.
SummitTX Capital first reported a position in Oscar Health in Q3 2025 and held it in 1 quarter.
SummitTX Capital's Oscar Health position peaked at $348K in Q3 2025.
341 funds tracked by Wall St. Rank held Oscar Health as of Q4 2025.

Based on SummitTX Capital's 13F filing for Q4 2025, filed 17 Feb 2026.